Standardized health plan reporting in four areas of preventive health care

American Journal of Preventive Medicine

Volumn 24, Issue 4, 2003, Pages 293-300

  Shih, Sarah C ^a   Bost, James E ^a   Pawlson, L Gregory ^a  

^a NATIONAL COMMITTEE FOR QUALITY ASSURANCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BLOOD PRESSURE REGULATION; CHILD; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE PLANNING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; MEDICAL INFORMATION; MEDICAL INFORMATION SYSTEM; MENOPAUSAL SYNDROME; PATIENT COMPLIANCE; PATIENT COUNSELING; PRESCHOOL CHILD; PRESCRIPTION; PREVENTIVE MEDICINE; QUALITY CONTROL; RATING SCALE; SCORING SYSTEM; SCREENING TEST; STANDARDIZATION; TASK PERFORMANCE;

EID: 0037404641     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-3797(03)00025-4     Document Type: Article

References (54)

1. InterStudy. HMO enrollment continues to decrease: InterStudy releases latest findings in its updated HMO industry report. Press release, May 7, 2001. www.hmodata.com/Pdf/ir111pr.pdf . Accessed on October 14, 2002.
2. Use of clinical preventive services by adults aged <65 years enrolled in health-maintenance organizations - United States, 1996. MMWR Morb Mortal Wkly Rep. 47:1998;613-619.
3. Fairbrother G., Freed G.L., Thompson J.W. Measuring immunization coverage. Am J Prev Med. 19:(suppl 3):2000;78-88.
4. Amonkar M.M., Madhavan S., Rosenbluth S.A., Odedina F.T., Simon K.J. Assessing managed care's role in promoting preventive care. J Community Health. 25:2000;225-240.
5. Harris J.R., Caldwell B., Cahill K. Measuring the public's health in an era of accountability lessons from HEDIS. Health Plan Employer Data and Information Set . Am J Prev Med. 14:(suppl 3):1998;9-13.
6. Rosenbaum S. Negotiating the new health system purchasing publicly accountable managed care . Am J Prev Med. 14:(suppl 3):1998;67-71.
7. Bodenheimer T. The American health care system - the movement for improved quality in health care. N Engl J Med. 340:1999;488-492.
8. Grimaldi P.L. New HEDIS means more information about HMOs. J Health Care Finance. 23:1997;40-50.
9. National Committee for Quality Assurance. HEDIS 2002, Vol. 1. Narrative: what's in it and why it matters. Washington DC: National Committee for Quality Assurance, 2002.
10. National Committee for Quality Assurance. Desirable attributes of HEDIS measures. Washington DC: National Committee for Quality Assurance, 1998.
11. Forecasted state-specific estimates of self-reported asthma prevalence - United States, 1998. MMWR Morb Mortal Wkly Rep. 47:1998;1022-1025.
12. Weiss S.T. The origins of childhood asthma. Monaldi Arch Chest Dis. 49:1994;154-158.
13. Barach E.M. Asthma in ambulatory care use of objective diagnostic criteria . J Fam Pract. 38:1994;161-165.
14. Perera B.J. Efficacy and cost effectiveness of inhaled steroids in asthma in a developing country. Arch Dis Child. 72:1995;312-315.
15. Ross R.N., Morris M., Sakowitz S.R., Berman B.A. Cost-effectiveness of including cromolyn sodium in the treatment program for asthma a retrospective, record-based study . Clin Ther. 10:1988;188-203.
16. Washington A.E., Johnson R.E., Sanders L.L. Jr. Chlamydia trachomatis infections in the United States what are they costing us? JAMA. 257:1987;2070-2072.
17. Magid D., Douglas J.M. Jr, Schwartz J.S. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections an incremental cost-effectiveness analysis . Ann Intern Med. 124:1996;389-399.
18. Magid D. Cost-effectiveness of Chlamydia screening for managed care organizations. Denver, CO: University of Colorado Health Sciences Center, 2001.
19. Mangione-Smith R., O'Leary J., McGlynn E.A. Health and cost-benefits of chlamydia screening in young women. Sex Transm Dis. 26:1999;309-316.
20. Nelson H.D., Helfand M. Screening for chlamydial infection. Am J Prev Med. 20:(suppl 3):2001;95-107.
21. Coffield A.B., Maciosek M.V., McGinnis J.M., et al. Priorities among recommended clinical preventive services. Am J Prev Med. 21:2001;1-9.
22. Burt V.L., Whelton P., Roccella E.J., et al. Prevalence of hypertension in the U.S. adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 25:1995;305-313.
23. Hammond C.B. HEDIS 2000 strategies for successful menopause management . Am J Manag Care. 6:(suppl 14):2000;738-741.
24. Kaufert P., Boggs P.P., Ettinger B., Woods N.F., Utian W.H. Women and menopause beliefs, attitudes, and behaviors. The North American Menopause Society 1997 Menopause Survey . Menopause. 5:1998;197-202.
25. Utian W.H., Boggs P.P. The North American Menopause Society 1998 Menopause Survey. Part I Postmenopausal women's perceptions about menopause and midlife . Menopause. 6:1999;122-128.
26. National Committee for Quality Assurance. HEDIS 2000, Vol. 5, HEDIS compliance audit: standards, policies and procedures. Washington DC: National Committee for Quality Assurance, 2000.
27. National Committee for Quality Assurance. HEDIS 2000, Vol. 2, Technical specifications. Washington DC: National Committee for Quality Assurance, 2000.
28. National Committee for Quality Assurance. HEDIS 2000, Vol. 3, Specifications for survey measures. Washington DC: National Committee for Quality Assurance, 2000.
29. National Committee for Quality Assurance. Quality assurance plan: HEDIS 2000 surveys. Washington DC: National Committee for Quality Assurance, October 28, 1999.
30. Mangione-Smith R., McGlynn E.A., Hiatt L. Screening for chlamydia in adolescents and young women. Arch Pediatr Adolesc Med. 154:2000;1108-1113.
31. Steinberg E.P. The impact of the new HEDIS guidelines practical considerations . Am J Manag Care. 6:(suppl 4):2000;190-196.
32. Diette G.B., Wu A.W., Skinner E.A., et al. Treatment patterns among adult patients with asthma factors associated with overuse of inhaled beta-agonists and underuse of inhaled corticosteroids . Arch Intern Med. 159:1999;2697-2704.
33. Nestor A., Calhoun A.C., Dickson M., Kalik C.A. Cross-sectional analysis of the relationship between national guideline recommended asthma drug therapy and emergency/hospital use within a managed care population. Ann Allergy Asthma Immunol. 81:1998;327-330.
34. Adams R.J., Fuhlbrigge A., Finkelstein J.A., et al. Use of inhaled anti-inflammatory medication in children with asthma in managed care settings. Arch Pediatr Adoles Med. 155:2001;501-507.
35. Thrall J.S., McCloskey L., Spivak H., Ettner S.L., Tighe J.E., Emans S.J. Performance of Massachusetts HMOs in providing Pap smear and sexually transmitted disease screening to adolescent females. J Adolesc Health. 22:1998;184-189.
36. Centers for Disease Control and Prevention. Youth Risk Behavior Surveillance - United States, 1999: sexual behaviors that contribute to unintended pregnancies and STDs, including HIV infection. MMWR CDC Surveill Summ 2000;49:19-21.
37. Hansson L. Current and future strategies in the treatment of hypertension. Am J Cardiol. 61:1988;2-7.
38. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 153:1993;154-183.
39. Harlan WR, Parsons PE, Thomas JW, et al. Health care utilization and costs of adult cardiovascular conditions, United States, 1980. Natl Med Care Util Expend Surv C 1989;7.
40. Bost J.E. Managed care organizations publicly reporting three years of HEDIS measures. Managed Care Interface. 14:2001;50-54.
41. National Committee for Quality Assurance. Quality profiles: in pursuit of excellence in managed care. Washington DC: National Committee for Quality Assurance, 1999.
42. National Committee for Quality Assurance. State of health care quality report: 2002. Available at: www.ncqa.org Accessed on October 14, 2002.
43. Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the Women's Health Initiative Randomized Controlled Trial . JAMA. 288:2002;321-333.
44. Petitti D.B. Hormone replacement therapy for prevention more evidence, more pessimism . JAMA. 288:2002;99-101.
45. Nelson H.D., Humphrey L.L., Nygren P., Teutsch S.M., Allan J.D. Postmenopausal hormone replacement therapy scientific review . JAMA. 288:2002;872-881.
46. Druss B.G., Rosenheck R.A., Sledge W.H. Health and disability costs of depressive illness in a major U.S. corporation. Am J Psychiatry. 157:2000;1274-1278.
47. Testa M.A., Simonson D.C. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus a randomized, controlled, double-blind trial . JAMA. 280:1998;1490-1496.
48. Burton W.N., Connerty C.M. Evaluation of a worksite-based patient education intervention targeted at employees with diabetes mellitus. J Occup Environ Med. 40:1998;702-706.
49. Weiss K.B., Gergen P.J., Hodgson T.A. An economic evaluation of asthma in the United States. N Engl J Med. 326:1992;862-866.
50. Krahn M.D., Berka C., Langlois P., Detsky A.S. Direct and indirect costs of asthma in Canada, 1990. CMAJ. 154:1996;821-831.
51. Bertera R.L. The effects of behavioral risks on absenteeism and health-care costs in the workplace. J Occup Med. 33:1991;1119-1124.
52. Braun K.L., Conybeare C.R. HealthScope a model for a low-cost health education program using commercial television . Public Health Rep. 110:1995;483-491.
53. Jencks S.F., Cuerdon T., Burwen D.R., et al. Quality of medical care delivered to Medicare beneficiaries a profile at state and national levels . JAMA. 284:2000;1670-1676.
54. Greenfield S., Kaplan S.H., Kahn R., Ninomiya J., Griffith J.L. Profiling care provided by different groups of physicians effects of patient case-mix (bias) and physician-level clustering on quality assessment results . Ann Intern Med. 136:2002;111-121.